Rizwana Islam

Rizwana Islam currently serves as the Senior Vice President and Head of Metabolism at Crosswalk Therapeutics, starting in November 2023. Previously, Rizwana held several positions at Takeda from January 2019, including Senior Director and Director, where responsibilities encompassed leading project teams and managing resources for various projects. At Shire, from June 2012 to January 2019, Rizwana acted as Associate Director and Senior Scientist, directing projects related to hematological disorders and collaborating with various departments to support transitions from Research to Development. Rizwana's academic credentials include a PhD in Biochemistry from Harvard University and a BA in Biology from Mount Holyoke College, with research experience gained at prominent institutions including Harvard and the Cambridge Institute for Medical Research.